Chemocentryx Stock Financials

CCXI
 Stock
  

USD 51.66  0.02  0.0387%   

Financial data analysis helps to double-check if markets are presently mispricing Chemocentryx. We have analyzed and interpolated thirty-four available fundamental indicators for Chemocentryx, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Chemocentryx financials, including its cash per share, market capitalization, and the relationship between the revenue and cash flow from operations . Given that Chemocentryx has a price to earning of 40.53 X, we suggest you to validate Chemocentryx prevailing market performance to make sure the company can sustain itself down the road. Use Chemocentryx to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a normal downward trend and little activity. Check odds of Chemocentryx to be traded at $51.14 in 90 days.
  
With this module, you can analyze Chemocentryx financials for your investing period. You should be able to track the changes in Chemocentryx individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Chemocentryx Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chemocentryx's financial statements are interrelated, with each one affecting the others. For example, an increase in Chemocentryx's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 1
Chemocentryx has less than 1 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Chemocentryx stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Chemocentryx's official financial statements usually reflect Chemocentryx's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Chemocentryx. For example, before you start analyzing numbers published by Chemocentryx accountants, it's critical to develop an understanding of what Chemocentryx's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Chemocentryx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemocentryx's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Chemocentryx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chemocentryx. Please utilize our Beneish M Score to check the likelihood of Chemocentryx's management to manipulate its earnings.

Chemocentryx Company Summary

Chemocentryx competes with Kikkoman Corp, Post Holdings, Lamb Weston, Grupo Bimbo, and Treehouse Foods. ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address835 Industrial Avenue
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.chemocentryx.com
Phone650 210 2900
CurrencyUSD - US Dollar
You should never invest in Chemocentryx without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chemocentryx Stock, because this is throwing your money away. Analyzing the key information contained in Chemocentryx's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Chemocentryx Key Financial Ratios

Generally speaking, Chemocentryx's financial ratios allow both analysts and investors to convert raw data from Chemocentryx's financial statements into concise, actionable information that can be used to evaluate the performance of Chemocentryx over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Chemocentryx reports annually and quarterly.

Chemocentryx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chemocentryx's current stock value. Our valuation model uses many indicators to compare Chemocentryx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemocentryx competition to find correlations between indicators driving Chemocentryx's intrinsic value. More Info.
Chemocentryx is number one stock in price to book category among related companies. It is number one stock in current ratio category among related companies fabricating about  0.51  of Current Ratio per Price to Book. The ratio of Price to Book to Current Ratio for Chemocentryx is roughly  1.95 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chemocentryx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chemocentryx's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemocentryx's earnings, one of the primary drivers of an investment's value.

Chemocentryx Systematic Risk

Chemocentryx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chemocentryx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-one with a total number of output elements of thirty. The Beta measures systematic risk based on how returns on Chemocentryx correlated with the market. If Beta is less than 0 Chemocentryx generally moves in the opposite direction as compared to the market. If Chemocentryx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chemocentryx is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chemocentryx is generally in the same direction as the market. If Beta > 1 Chemocentryx moves generally in the same direction as, but more than the movement of the benchmark.
.

About Chemocentryx Financials

What exactly are Chemocentryx Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Chemocentryx's income statement, its balance sheet, and the statement of cash flows. Potential Chemocentryx investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Chemocentryx investors may use each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Chemocentryx is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Chemocentryx has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Chemocentryx Thematic Clasifications

Chemocentryx is part of several thematic ideas from Biotech to Cancer Fighters. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Biotech Idea
BiotechView
Cancer Fighters Idea
Cancer FightersView

Chemocentryx October 1, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Chemocentryx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chemocentryx. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chemocentryx based on widely used predictive technical indicators. In general, we focus on analyzing Chemocentryx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemocentryx's daily price indicators and compare them against related drivers.
Downside Deviation2.52
Information Ratio0.1278
Maximum Drawdown109.7
Value At Risk(4.23)
Potential Upside4.49
Continue to Trending Equities. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Chemocentryx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemocentryx. If investors know Chemocentryx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemocentryx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.